Current evidence supports the view that glioma cells secrete a large amount of the excitatory neurotransmitter glutamate, and this is primarily mediated by the xCT cystine/glutamate antiporter, whose level is increased on the synaptic surface of glioma cells [1,7]. The gene discussed is SLC7A11; the disease is central nervous system cancer.